Teratological effects of a panel of sixty water-soluble toxicants on zebrafish development.

The zebrafish larva is a promising whole-animal model for safety pharmacology, environmental risk assessment, and developmental toxicity. This model has been used for the high-throughput toxicity screening of various compounds. Our aim here is to identify possible phenotypic markers of teratogenicity in zebrafish embryos that could be used for the assaying compounds for reproductive toxicity. We have screened a panel of 60 water-soluble toxicants to examine their effects on zebrafish development. A total of 22,080 wild-type zebrafish larvae were raised in 250 μL defined buffer in 96-well plates at a plating density of one embryo per well. They were exposed for a 96-h period starting at 24 h post-fertilization. A logarithmic concentration series was used for range-finding, followed by a narrower geometric series for developmental toxicity assessment. A total of 9017 survivors were analyzed at 5 days post-fertilization for nine phenotypes, namely, (1) normal, (2) pericardial oedema, (3) yolk sac oedema, (4) melanophores dispersed, (5) bent tail tip, (6) bent body axis, (7) abnormal Meckel's cartilage, (8) abnormal branchial arches, and (9) uninflated swim bladder. For each toxicant, the EC50 (concentration required to produce one or more of these abnormalities in 50% of embryos) was also calculated. For the majority of toxicants (55/60) there was, at the population level, a statistically significant, concentration-dependent increase in the incidence of abnormal phenotypes among survivors. The commonest abnormalities were pericardial oedema, yolk sac oedema, dispersed melanophores, and uninflated swim bladder. It is possible therefore that these could prove to be general indicators of reproductive toxicity in the zebrafish embryo assay.

[1]  Patricia McGrath,et al.  Zebrafish: a preclinical model for drug screening. , 2002, Assay and drug development technologies.

[2]  M. Kent,et al.  The State of the Art of the Zebrafish Model for Toxicology and Toxicologic Pathology Research—Advantages and Current Limitations , 2003, Toxicologic pathology.

[3]  Shicui Zhang,et al.  Evaluation of cytotoxicity, genotoxicity and teratogenicity of marine sediments from Qingdao coastal areas using in vitro fish cell assay, comet assay and zebrafish embryo test. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[4]  Y. Yan,et al.  Zebrafish comparative genomics and the origins of vertebrate chromosomes. , 2000, Genome research.

[5]  R. Blust,et al.  Feasibility study of the zebrafish assay as an alternative method to screen for developmental toxicity and embryotoxicity using a training set of 27 compounds. , 2012, Reproductive toxicology.

[6]  C. Osgood,et al.  Silver nanoparticles induce developmental stage-specific embryonic phenotypes in zebrafish. , 2013, Nanoscale.

[7]  G. Holcombe,et al.  Metal toxicity to embryos and larvae of eight species of freshwater fish—II: Copper , 1978, Bulletin of environmental contamination and toxicology.

[8]  Stephen T. C. Wong,et al.  Phenotypic analysis of images of zebrafish treated with Alzheimer's γ-secretase inhibitors , 2010, BMC biotechnology.

[9]  Julieta M. Panzica-Kelly,et al.  Development of a zebrafish embryo teratogenicity assay and quantitative prediction model. , 2010, Birth defects research. Part B, Developmental and reproductive toxicology.

[10]  H. Yost,et al.  Cardiac morphology and blood pressure in the adult zebrafish , 2001, The Anatomical record.

[11]  H. Roche,et al.  Acute and chronic toxicities of colchicine in Brachydanio rerio , 1994, Bulletin of environmental contamination and toxicology.

[12]  Wu Dong,et al.  Zebrafish as a novel experimental model for developmental toxicology , 2003, Congenital anomalies.

[13]  Z. Svobodová,et al.  Effect of four selected carrier solvents on embryonal stages of Danio rerio. , 2012, Neuro endocrinology letters.

[14]  N. Sylvain,et al.  Zebrafish embryos exposed to alcohol undergo abnormal development of motor neurons and muscle fibers. , 2010, Neurotoxicology and teratology.

[15]  Thomas B Knudsen,et al.  Zebrafish: as an integrative model for twenty-first century toxicity testing. , 2011, Birth defects research. Part C, Embryo today : reviews.

[16]  Aldert H Piersma,et al.  Relative embryotoxicity of two classes of chemicals in a modified zebrafish embryotoxicity test and comparison with their in vivo potencies. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[17]  J. Llobet,et al.  Assessment of developmental delay in the zebrafish embryo teratogenicity assay. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[18]  R. Geisler,et al.  Differential gene expression as a toxicant-sensitive endpoint in zebrafish embryos and larvae. , 2007, Aquatic toxicology.

[19]  T. Foroud,et al.  Pdgfra protects against ethanol-induced craniofacial defects in a zebrafish model of FASD , 2013, Development.

[20]  A. Ornoy,et al.  Pregnancy outcome after in utero exposure to colchicine. , 2010, American journal of obstetrics and gynecology.

[21]  S. Shibata,et al.  A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice. , 2000, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[22]  Mark A McPeek,et al.  Estimating metazoan divergence times with a molecular clock. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Roach,et al.  Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery , 2008, British journal of pharmacology.

[24]  V. Tropepe,et al.  Can zebrafish be used as a model to study the neurodevelopmental causes of autism? , 2003, Genes, brain, and behavior.

[25]  C. Cámara,et al.  Bioconcentration of pesticides in zebrafish eleutheroembryos (Danio rerio). , 2012, The Science of the total environment.

[26]  S. Haggarty,et al.  Zebrafish Behavioral Profiling Links Drugs to Biological Targets and Rest/Wake Regulation , 2010, Science.

[27]  R. Nagel,et al.  Bioconcentration, metabolism and toxicity of substituted anilines in the zebrafish (Brachydanio rerio). , 1991, The Science of the total environment.

[28]  T. Braunbeck,et al.  Cartilage and bone malformations in the head of zebrafish (Danio rerio) embryos following exposure to disulfiram and acetic acid hydrazide. , 2013, Toxicology and applied pharmacology.

[29]  Prakash D Nallathamby,et al.  In vivo imaging of transport and biocompatibility of single silver nanoparticles in early development of zebrafish embryos. , 2007, ACS nano.

[30]  B. Ansari,et al.  Malathion toxicity: effect on the liver of the fish Brachydanio rerio (Cyprinidae). , 1986, Ecotoxicology and environmental safety.

[31]  Susan Budavari,et al.  The Merck index : an encyclopedia of chemicals, drugs, and biologicals , 1983 .

[32]  L. Zon,et al.  Zebrafish: a model system for the study of human disease. , 2000, Current opinion in genetics & development.

[33]  Richard E Peterson,et al.  Zebrafish as a model vertebrate for investigating chemical toxicity. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[34]  H. Cuckle,et al.  Chromosomal abnormalities and birth defects among couples with colchicine treated familial Mediterranean fever. , 2005, American journal of obstetrics and gynecology.

[35]  P. Currie,et al.  Animal models of human disease: zebrafish swim into view , 2007, Nature Reviews Genetics.

[36]  A. Rubinstein,et al.  Zebrafish: from disease modeling to drug discovery. , 2003, Current opinion in drug discovery & development.

[37]  R. Nagel,et al.  Toxicity of lindane, atrazine, and deltamethrin to early life stages of zebrafish (Brachydanio rerio). , 1990, Ecotoxicology and environmental safety.

[38]  A. Jurand Teratogenic activity of lithium carbonate: an experimental update. , 1988, Teratology.

[39]  Patricia McGrath,et al.  Zebrafish: a predictive model for assessing drug-induced toxicity. , 2008, Drug discovery today.

[40]  Jerry Westerweel,et al.  Zebrafish embryo development in a microfluidic flow-through system. , 2011, Lab on a chip.

[41]  X. He,et al.  Effects of copper nanoparticles on the development of zebrafish embryos. , 2010, Journal of nanoscience and nanotechnology.

[42]  A. Hill,et al.  Zebrafish developmental toxicity assay: A fishy solution to reproductive toxicity screening, or just a red herring? , 2011, Reproductive toxicology.

[43]  Michael K. Richardson,et al.  Large-Scale Analysis of Acute Ethanol Exposure in Zebrafish Development: A Critical Time Window and Resilience , 2011, PloS one.

[44]  P. Marsalek,et al.  Acute toxicity of acetylsalicylic acid to juvenile and embryonic stages of Danio rerio. , 2013, Neuro endocrinology letters.

[45]  Xiaoshan Zhu,et al.  Toxicity Assessment of Iron Oxide Nanoparticles in Zebrafish (Danio rerio) Early Life Stages , 2012, PloS one.

[46]  N. A. Shazili,et al.  Variable sensitivity of rainbow trout (Salmo gairdneri) eggs and alevins to heavy metals , 1986, Bulletin of environmental contamination and toxicology.

[47]  Shaukat Ali,et al.  Large-Scale Assessment of the Zebrafish Embryo as a Possible Predictive Model in Toxicity Testing , 2011, PloS one.

[48]  Lisa Truong,et al.  Evaluation of embryotoxicity using the zebrafish model. , 2011, Methods in molecular biology.

[49]  A. Meijer,et al.  Discovery of a functional glucocorticoid receptor beta-isoform in zebrafish. , 2008, Endocrinology.

[50]  R. Gerlai,et al.  Fishing for genes influencing vertebrate behavior: zebrafish making headway , 2006, Lab Animal.

[51]  Calum A. MacRae,et al.  Drugs That Induce Repolarization Abnormalities Cause Bradycardia in Zebrafish , 2003, Circulation.

[52]  Chao Song,et al.  Transmembrane distribution of kanamycin and chloramphenicol: insights into the cytotoxicity of antibacterial drugs. , 2010, Molecular bioSystems.

[53]  Rob Wallis,et al.  Zebrafish assays as early safety pharmacology screens: paradigm shift or red herring? , 2008, Journal of pharmacological and toxicological methods.

[54]  Wim De Coen,et al.  Development of a screening assay to identify teratogenic and embryotoxic chemicals using the zebrafish embryo. , 2009, Reproductive toxicology.

[55]  Shaukat Ali,et al.  Developmental effects of cannabinoids on zebrafish larvae. , 2013, Zebrafish.

[56]  Su Guo,et al.  Using zebrafish to assess the impact of drugs on neural development and function , 2009, Expert opinion on drug discovery.

[57]  Robert Geisler,et al.  Learning from Small Fry: The Zebrafish as a Genetic Model Organism for Aquaculture Fish Species , 2006, Marine Biotechnology.

[58]  T. Braunbeck,et al.  Dechorionation as a tool to improve the fish embryo toxicity test (FET) with the zebrafish (Danio rerio). , 2011, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[59]  Edwin Cuppen,et al.  Zebrafish development and regeneration: new tools for biomedical research. , 2009, The International journal of developmental biology.

[60]  P. Ville,et al.  Acute Toxicity, Toxicokinetics, and Tissue Target of Lead and Uranium in the Clam Corbicula fluminea and the Worm Eisenia fetida: Comparison with the Fish Brachydanio rerio , 1999, Archives of environmental contamination and toxicology.

[61]  Jill A. Morris,et al.  Zebrafish: a model system to examine the neurodevelopmental basis of schizophrenia. , 2009, Progress in brain research.

[62]  Jan Maes,et al.  Evaluation of 14 Organic Solvents and Carriers for Screening Applications in Zebrafish Embryos and Larvae , 2012, PloS one.

[63]  J. Eisen,et al.  Headwaters of the zebrafish — emergence of a new model vertebrate , 2002, Nature Reviews Genetics.

[64]  B. Halling‐Sørensen,et al.  The toxic effect of the antibiotic metronidazole on aquatic organisms. , 1997, Chemosphere.

[65]  Jeanne Garric,et al.  Development of a zebrafish 4-day embryo-larval bioassay to assess toxicity of chemicals. , 2006, Ecotoxicology and environmental safety.

[66]  C. Claudianos,et al.  Big ideas for small brains: what can psychiatry learn from worms, flies, bees and fish? , 2011, Molecular Psychiatry.

[67]  Nicole A. Ducharme,et al.  Developmental toxicity screening in zebrafish. , 2011, Birth defects research. Part C, Embryo today : reviews.

[68]  Matthew B Veldman,et al.  Zebrafish as a Developmental Model Organism for Pediatric Research , 2008, Pediatric Research.

[69]  S. Guo,et al.  Linking genes to brain, behavior and neurological diseases: what can we learn from zebrafish? , 2004, Genes, brain, and behavior.

[70]  G. Whale,et al.  An information-rich alternative, chemicals testing strategy using a high definition toxicogenomics and zebrafish (Danio rerio) embryos. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[71]  Robert Rallo,et al.  Use of a high-throughput screening approach coupled with in vivo zebrafish embryo screening to develop hazard ranking for engineered nanomaterials. , 2011, ACS nano.

[72]  Aldert H Piersma,et al.  Concentration-response analysis of differential gene expression in the zebrafish embryotoxicity test following flusilazole exposure. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[73]  F. Rodríguez,et al.  Spatial memory and hippocampal pallium through vertebrate evolution: insights from reptiles and teleost fish , 2002, Brain Research Bulletin.

[74]  Shaukat Ali,et al.  Zebrafish embryos and larvae: a new generation of disease models and drug screens. , 2011, Birth defects research. Part C, Embryo today : reviews.

[75]  Elizabeth N Schock,et al.  The effects of carbaryl on the development of zebrafish (Danio rerio) embryos. , 2012, Zebrafish.

[76]  Michael K. Richardson,et al.  Behavioral profiling of zebrafish embryos exposed to a panel of 60 water-soluble compounds , 2012, Behavioural Brain Research.

[77]  Thomas Knudsen,et al.  Predictive models and computational toxicology. , 2013, Methods in molecular biology.

[78]  Gareth J Waldron,et al.  Zebrafish based assays for the assessment of cardiac, visual and gut function--potential safety screens for early drug discovery. , 2008, Journal of pharmacological and toxicological methods.

[79]  M. Richardson,et al.  The use of the zebrafish model in stress research , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[80]  L. Zon,et al.  In vivo drug discovery in the zebrafish , 2005, Nature Reviews Drug Discovery.

[81]  M. Holdiness Teratology of the antituberculosis drugs. , 1987, Early human development.

[82]  Mehmet Fatih Yanik,et al.  High-throughput in vivo vertebrate screening , 2010, Nature Methods.

[83]  Julieta M. Panzica-Kelly,et al.  Zebrafish embryo developmental toxicology assay. , 2012, Methods in molecular biology.

[84]  C. Kimmel,et al.  Stages of embryonic development of the zebrafish , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[85]  M. Hammerschmidt,et al.  How to make a teleost adenohypophysis: Molecular pathways of pituitary development in zebrafish , 2009, Molecular and Cellular Endocrinology.

[86]  Anton J. Enright,et al.  The zebrafish reference genome sequence and its relationship to the human genome , 2013, Nature.